comparemela.com

Latest Breaking News On - Living therapeutics initiative - Page 1 : comparemela.com

Sickle Cell Clinical Trial Aims to Cure Disease by Correcting Patient s Mutated Gene

Sickle cell disease is a genetic blood disorder that affects the structure and function of hemoglobin, reduces the ability of red blood cells to transport oxygen efficiently, and progresses to a chronic vascular disease that affects approximately 100,000 Americans and millions worldwide, with a disproportionate effect on the Black community. | Benioff Children’s Oakland Receives $17M in Grants to Launch 4-Year Study Using CRISPR to Eradicate Sickle Cell Mutation By Lorna Fernandes UCSF Benioff Children’s Hospital Oakland has received the largest research trial grant in its history to launch an innovative clinical trial that aims to cure sickle cell disease. The study, which plans to enroll […]

Novel CRISPR Tool Activates Instead of Editing Human Immune Cell Genes

A research team used a method called CRISPRa to activate each gene in the genome in different cells, enabling them to test almost 20,000 genes in parallel. This allowed them to quickly learn the rules about which genes provide the most powerful levers to reprogram cell functions in ways that could eventually lead to more powerful immunotherapies.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.